Insight into the gut microbiome dysbiosis in patients with liver failure after extended-hepatectomy

por Xie, Feihu, Bazhabayi, Meiheban, Li, Binkui, Yuan, Yunfei
Publicado 2022

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma

por Lin, Zhu, Huang, Zhenkun, Shi, Yunxing, Yuan, Yichuan, Niu, Yi, Li, Binkui, Yuan, Yunfei, Qiu, Jiliang
Publicado 2023

Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature

por Huang, Jun, Li, Qijiong, Zheng, Yun, Shen, Jingxian, Li, Binkui, Zou, Ruhai, Wang, Jianping, Yuan, Yunfei
Publicado 2014

Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma

por Li, Binkui, He, Liru, Zuo, Dinglan, He, Wei, Wang, Yongjin, Zhang, Yuanping, Liu, Wenwu, Yuan, Yunfei
Publicado 2017

Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome?

por Li, Binkui, Yuan, Yunfei, Chen, Guihua, He, Liru, Zhang, Yaqi, Li, Jinqing, Li, Guohui, Lau, Wan Yee
Publicado 2010

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma

por Qiu, Jiliang, Huang, Pinzhu, Liu, Qian, Hong, Jian, Li, Binkui, Lu, Canliang, Wang, Li, Wang, Jianping, Yuan, Yunfei
Publicado 2011

Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence

por Tao, Qiang, He, Wei, Li, Binkui, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, Liu, Wenwu, Zhang, Yuanping, Yuan, Yunfei
Publicado 2018

Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

por Liu, Wenwu, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, He, Wei, Yang, Zhiwen, Zhang, Yuanping, Li, Binkui, Yuan, Yunfei
Publicado 2018

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition

por Zhang, Yuanping, Qiu, Jiliang, Zuo, Dinglan, Yuan, Yichuan, Qiu, Yuxiong, Qiao, Liang, He, Wei, Li, Binkui, Yuan, Yunfei
Publicado 2021

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition

por Bi, Fangfang, Qiu, Yuxiong, Wu, Zongfeng, Liu, Shaoru, Zuo, Dinglan, Huang, Zhenkun, Li, Binkui, Yuan, Yunfei, Niu, Yi, Qiu, Jiliang
Publicado 2023

Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study

por Zeng, Qing-An, Qiu, Jiliang, Zou, Ruhai, Li, Yijie, Li, Shengping, Li, Binkui, Huang, Pinzhu, Hong, Jian, Zheng, Yun, Lao, Xiangming, Yuan, Yunfei
Publicado 2012

Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4

por He, Liru, Deng, Haixia, Liu, Shiliang, Chen, Jiewei, Li, Binkui, Wang, Chenyuan, Wang, Xin, Jiang, Yiguo, Ma, Ningfang, Liu, Mengzhong, Xie, Dan
Publicado 2018

Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation

por Wen, Lei, Chen, Zhigang, Ji, Xiaomeng, Fong, William Pat, Shao, Qiong, Ren, Chao, Cai, Yanyu, Li, Binkui, Yuan, Yunfei, Wang, Deshen, Li, Yuhong
Publicado 2022

Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma

por Li, Keren, Niu, Yi, Li, Kai, Zhong, Chengrui, Qiu, Zhiyu, Yuan, Yichuan, Shi, Yunxing, Lin, Zhu, Huang, Zhenkun, Zuo, Dinglan, Yuan, Yunfei, Li, Binkui
Publicado 2023

Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study

por He, Wei, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, Yang, Junping, Qiu, Jiliang, Tao, Qiang, Liu, Wenwu, Yang, Zhiwen, Zhang, Yuanping, Li, Binkui, Yuan, Yunfei
Publicado 2018

NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3

por Zhang, Yuanping, Zuo, Dinglan, Qiu, Jiliang, Li, Kai, Niu, Yi, Yuan, Yichuan, Qiu, Yuxiong, Qiao, Liang, He, Wei, Wang, Chenwei, Yuan, Yunfei, Li, Binkui
Publicado 2022

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

por Yuan, Yichuan, He, Wei, Yang, Zhiwen, Qiu, Jiliang, Huang, Zhenkun, Shi, Yunxing, Lin, Zhu, Zheng, Yun, Chen, Minshan, Lau, Wan Yee, Li, Binkui, Yuan, Yunfei
Publicado 2023

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma

por Li, Binkui, Qiu, Jiliang, Zheng, Yun, Shi, Yunxing, Zou, Ruhai, He, Wei, Yuan, Yichuang, Zhang, Yuanping, Wang, Chenwei, Qiu, Zhiyu, Li, Kai, Zhong, Chengrui, Yuan, Yunfei
Publicado 2021

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis

por He, Wei, Zeng, Qingli, Zheng, Yun, Chen, Meixian, Shen, Jingxian, Qiu, Jiliang, Chen, Miao, Zou, Ruhai, Liao, Yadi, Li, Qijiong, Wu, Xianqiu, Li, Binkui, Yuan, Yunfei
Publicado 2015

Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study

por Qiu, Zhiyu, Shen, Lujun, Jiang, Yiquan, Qiu, Jiliang, Xu, Zining, Shi, Mengting, Yu, Zhentao, Ma, Yanping, He, Wei, Zheng, Yun, Li, Binkui, Wang, Guoying, Yuan, Yunfei
Publicado 2021